Hematologic and solid-organ malignancy risk in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

Arjun Mahajan; Dorsa Moslehi; David W. Bates

doi:10.1038/s43856-025-01275-x

December 7, 2025Communications MedicineOpen Access

Hematologic and solid-organ malignancy risk in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

View Full Paper

Ask AI

Bookmark

Share

Key Points

Increased malignancy risk identified in specific patient populations with AAV, indicating a need for tailored approaches.
Findings revealed a strong correlation between AAV and heightened risk for hematologic and solid-organ malignancies.
Assessment used real-world evidence from large-scale patient data to derive conclusions about cancer risk in AAV cases.
Results highlight potential for improved cancer surveillance strategies for patients suffering from ANCA-associated vasculitis.

Implication

Analysis finds increased malignancy risk in patients with ANCA-associated vasculitis, suggesting improved surveillance strategies.

Abstract

Patients with AAV face distinct and heightened risks for select hematologic and solid-organ malignancies, supporting the need for tailored cancer surveillance strategies. These findings provide a large-scale, real-world evidence base for malignancy risk stratification and proactive screening in AAV.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mahajan et al. (2025) studied this question.

synapsesocial.com/papers/694020e82d562116f28faea6 https://doi.org/10.1038/s43856-025-01275-x

View Full Paper

Ask AI

Bookmark

Share

Hematologic and solid-organ malignancy risk in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

Key Points

Implication

Abstract

Discussion

Cite This Study

Hematologic and solid-organ malignancy risk in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading